Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 9715 KEY WEST AVENUE, ROCKVILLE, MD
- Founded
- Not disclosed
📈 Company Timeline
Supernus Pharmaceuticals, Inc. reported Operating or financial results
Supernus Pharmaceuticals, Inc. filed an 8-K covering operating or financial results.
Supernus Pharmaceuticals, Inc. reported Shareholder voting results
Supernus Pharmaceuticals, Inc. filed an 8-K covering shareholder voting results, supporting financial statements or exhibits.
Supernus Pharmaceuticals, Inc. business combination filing
Supernus Pharmaceuticals, Inc. filed Form 425 (communications about a business combination).
Supernus Pharmaceuticals, Inc. proxy and shareholder-vote filing
Supernus Pharmaceuticals, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.
Supernus Pharmaceuticals, Inc. merger vote filing
Supernus Pharmaceuticals, Inc. filed Form DEFM14A (definitive merger proxy).
Capital Structure & Financial Position
Financial strength and liquidity analysisPeer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |